{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T09:03:58Z","timestamp":1718701438519},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,4]]},"DOI":"10.7759\/cureus.14839","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T13:52:58Z","timestamp":1620136378000},"source":"Crossref","is-referenced-by-count":2,"title":["Anti-Muscle Specific Kinase (Anti-MuSK) Positive Myasthenia Gravis Overlapping With Parkinson\u2019s Disease: A Challenging Diagnosis"],"prefix":"10.7759","author":[{"given":"Mohammed S","family":"Albassam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman A","family":"Thabet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Hmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seraj","family":"Makkawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2015.10.009","article-title":"Epidemiology of myasthenia gravis in Ontario, Canada","volume":"26","author":"Breiner A","year":"2016","unstructured":"Breiner A, Widdifield J, Katzberg HD, Barnett C, Bril V, Tu K. Epidemiology of myasthenia gravis in Ontario, Canada. Neuromuscul Disord. 2016, 26:41-6. 10.1016\/j.nmd.2015.10.009","journal-title":"Neuromuscul Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24348","article-title":"Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa","volume":"51","author":"Mombaur B","year":"2015","unstructured":"Mombaur B, Lesosky MR, Liebenberg L, Vreede H, Heckmann JM. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa. Muscle Nerve. 2015, 51:533-7. 10.1002\/mus.24348","journal-title":"Muscle Nerve"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23271","article-title":"Geographical distribution of a seropositive myasthenia gravis population","volume":"45","author":"Heldal AT","year":"2012","unstructured":"Heldal AT, Eide GE, Gilhus NE, Romi F. Geographical distribution of a seropositive myasthenia gravis population. Muscle Nerve. 2012, 45:815-9. 10.1002\/mus.23271","journal-title":"Muscle Nerve"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr AS","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010, 10:46. 10.1186\/1471-2377-10-46","journal-title":"BMC Neurol"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus NE","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015, 14:1023-36.","journal-title":"Lancet Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau LM","year":"2006","unstructured":"de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006, 5:525-35. 10.1016\/S1474-4422(06)70471-9","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56010005","article-title":"Patients with Parkinson's disease and myasthenia gravis-a report of three new cases and review of the literature","volume":"56","author":"Odajiu I","year":"2019","unstructured":"Odajiu I, Davidescu EI, Mitu C, Popescu BO. Patients with Parkinson's disease and myasthenia gravis-a report of three new cases and review of the literature. Medicina (Kaunas). 2019, 56:5. 10.3390\/medicina56010005","journal-title":"Medicina (Kaunas)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2013.01.018","article-title":"Parkinson disease: from pathology to molecular disease mechanisms","volume":"62","author":"Dexter DT","year":"2013","unstructured":"Dexter DT, Jenner P. Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med. 2013, 62:132-44. 10.1016\/j.freeradbiomed.2013.01.018","journal-title":"Free Radic Biol Med"},{"key":"ref9","article-title":"A study of salivary secretion in Parkinson's disease","volume":"22","author":"Bagheri H","year":"1999","unstructured":"Bagheri H, Damase-Michel C, Lapeyre-Mestre M, et al.. A study of salivary secretion in Parkinson's disease. Clin Neuropharmacol. 1999, 22:213-5.","journal-title":"Clin Neuropharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/mds.1203","article-title":"Gastric emptying time and gastric motility in patients with Parkinson's disease","volume":"16","author":"Hardoff R","year":"2001","unstructured":"Hardoff R, Sula M, Tamir A, et al.. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord. 2001, 16:1041-7. 10.1002\/mds.1203","journal-title":"Mov Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"26","author":"Schapira AH","year":"2011","unstructured":"Schapira AH, Jenner P. Etiology and pathogenesis of Parkinson's disease. Mov Disord. 2011, 26:1049-55. 10.1002\/mds.23732","journal-title":"Mov Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-53145-4_5","article-title":"Neuromuscular emergencies in the neuroscience intensive care unit","author":"Chandrasekaran PN","year":"2020","unstructured":"Chandrasekaran PN, Pandey A, Idiculla PS. Neuromuscular emergencies in the neuroscience intensive care unit. Neuromuscular Urgencies and Emergencies. Arora N, Govindarajan R, Kataria S, Nattanmai Chandrasekaran P (ed): Springer, Cham, Switzerland; 2020. 95-129. 10.1007\/978-3-030-53145-4_5"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/859802","article-title":"Anti-MuSK-positive myasthenia gravis in a patient with parkinsonism and cognitive impairment","volume":"2011","author":"Lanfranconi S","year":"2011","unstructured":"Lanfranconi S, Corti S, Baron P, Conti G, Borellini L, Bresolin N, Bersano A. Anti-MuSK-positive myasthenia gravis in a patient with parkinsonism and cognitive impairment. Neurol Res Int. 2011, 2011:859802. 10.1155\/2011\/859802","journal-title":"Neurol Res Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson's disease and parkinsonism","volume":"132","author":"Hayes MT","year":"2019","unstructured":"Hayes MT. Parkinson's disease and parkinsonism. Am J Med. 2019, 132:802-7. 10.1016\/j.amjmed.2019.03.001","journal-title":"Am J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus NE","year":"2016","unstructured":"Gilhus NE. Myasthenia gravis. N Engl J Med. 2016, 375:2570-81. 10.1056\/NEJMra1602678","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/57674-anti-muscle-specific-kinase-anti-musk-positive-myasthenia-gravis-overlapping-with-parkinsons-disease-a-challenging-diagnosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:19Z","timestamp":1707507199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/57674-anti-muscle-specific-kinase-anti-musk-positive-myasthenia-gravis-overlapping-with-parkinsons-disease-a-challenging-diagnosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.14839","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,4]]}}}